Results 91 to 100 of about 13,841 (201)

The Herpes Zoster Patient Pathway and Gaps in Current Vaccination Guidelines in Southeast Asia: Summary of a Zoster Experts’ Network Scientific Workshop

Vaccines
The burden of herpes zoster (HZ) is recognized worldwide; however, there is seemingly limited information on incidence and vaccination practices in Southeast Asia (SEA).
Gyneth Lourdes G. Bibera, Peter San Martin, Desiree A. M. van Oorschot, Afif Nurul Hidayati, Deliana Permatasari, Sasheela Sri La Sri Ponnampalavanar, Kughan Govinden, Maria Christina Filomena Batac, Joselito Javier, Terapong Tantawichien, Phatu Boonmahittisut, Trinh Minh Trang, Thanh Tuyen Dang Thi   +12 more
doaj   +1 more source

Management and Prevention of Herpes Zoster: A Canadian Perspective

Canadian Journal of Infectious Diseases and Medical Microbiology, 2010
Varicella-zoster virus reactivation leads to herpes zoster – the main complication of which is postherpetic neuralgia (PHN). Rapid antiviral therapy initiated within 72 h of rash onset has been shown to accelerate rash healing, reduce the duration of ...
Guy Boivin, Roman Jovey, Catherine T Elliott, David M Patrick   +3 more
doaj   +1 more source

Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new data

Современная ревматология
Patients with immune-mediated inflammatory rheumatic diseases (IIRD) are more likely to develop herpes zoster (HZ) than individuals in the general population.
N. V. Muravyova, B. S. Belov
doaj   +1 more source

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany

Human Vaccines & Immunotherapeutics, 2017
The aim of this study was to compare the public health impact of introducing 2 Herpes Zoster (HZ) vaccines, Zoster Vaccine Live (ZVL) versus a non-live adjuvanted subunit candidate vaccine (HZ/su), in the German population aged 50+ years split into 3 age
Desmond Curran, Desirée Van Oorschot, Lijoy Varghese, Lidia Oostvogels, Tomas Mrkvan, Romulo Colindres, Alfred von Krempelhuber, Anastassia Anastassopoulou   +7 more
doaj   +1 more source

Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature

Frontiers in Immunology, 2018
This narrative review focuses on the herpes zoster (HZ) and its prevention in transplant patients. Varicella zoster virus (VZV) is highly contagious and distributed worldwide in humans.
Lei Wang, Erik A. M. Verschuuren, Coretta C. van Leer-Buter, Stephan J. L. Bakker, Anoek A. E. de Joode, Johanna Westra, Nicolaas A. Bos   +6 more
doaj   +1 more source

Candidate for a live vaccine?

Journal of Family Medicine and Primary Care, 2017
Immune dysfunction is a well-known phenomenon in end-stage liver disease (ESLD). The pretransplant period offers a unique window for primary care physicians to optimize the transplant's vaccine protection before antirejection medications are initiated ...
Justin Ralph Abbatemarco, Alan Taege
doaj   +1 more source

Baculovirus Vector-Based Varicella-Zoster Virus Vaccine as a Promising Alternative with Enhanced Safety and Therapeutic Functions

Vaccines
Varicella-zoster virus (VZV) poses lifelong risks, causing varicella and herpes zoster (HZ, shingles). Currently, varicella and HZ vaccines are predominantly live attenuated vaccines or adjuvanted subunit vaccines utilizing VZV glycoprotein E (gE). Here,
Chanyeong Lee, Minjee Kim, Jungmin Chun, Sehyun Kim, Doyoung Yoon, Hyeondong Lee, Heewon Bang, Hee-Jung Lee, Hosun Park, Young Bong Kim   +9 more
doaj   +1 more source

Is it safe to vaccinate children against varicella while they're in close contact with a pregnant woman? [PDF]

, 2011
All healthy children without evidence of immunity to varicella who are living in a household with a susceptible pregnant woman should be vaccinated (strength of recommendation [SOR]: C, expert opinion).
Flake, Donna, Kertesz, Joseph, Merlo, Heather C., Meyer, Albert A., Vaid, Shalini K.   +4 more
core  

A self-controlled case series study on the safety of a live attenuated herpes zoster vaccine in China

Expert Review of Vaccines
Background Herpes zoster (HZ), caused by varicella-zoster virus, primarily affects the elderly. In May 2023, the first domestically produced live attenuated zoster vaccine was approved for use in adults aged 40 years or older in China.Research design and
Xiang Cao, Mingwei Wei, Xiang Huo, Yuanbao Liu, Ming Xu, Xiaoshan Wang, Xianzhang Huang, Hui Ma, Na Xu, Qiang Lu, Shihua Ma, Pengfei Jin, Jingxin Li   +12 more
doaj   +1 more source

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives. [PDF]

, 2019
Tofacitinib is an oral Janus kinase inhibitor approved for the treatment of psoriatic arthritis (PsA). It provides an alternative option for patients who have had an inadequate response and tolerance to other disease modifying antirheumatic drugs (DMARDs)
Beck, Kristen M, Liao, Wilson, Ly, Karen, Orbai, Ana-Maria, Smith, Mary P   +4 more
core